Literature DB >> 16547280

CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Damian M Kraus1, Gary S Elliott, Hilary Chute, Thomas Horan, Karl H Pfenninger, Staci D Sanford, Stephen Foster, Sheila Scully, Andrew A Welcher, V Michael Holers.   

Abstract

In this study, we describe the identification and in vitro functional activity of a novel multiple domain complement regulatory protein discovered based on its homology to short consensus repeat (SCR)-containing proteins of the regulators of complement activation (RCA) gene family. The rat cDNA encodes a predicted 388-kDa protein consisting of 14 N-terminal CUB domains that are separated from each other by a SCR followed by 15 tandem SCR domains, a transmembrane domain, and a short cytoplasmic tail. This protein is the homolog of the human protein of unknown function called the CUB and sushi multiple domains 1 (CSMD1) protein. A cloning strategy that incorporates the two C-terminal CUB-SCR domains and 12 of the tandem SCR repeats was used to produce a soluble rat CSMD1 protein. This protein blocked classical complement pathway activation in a comparable fashion with rat Crry but did not block alternative pathway activation. Analysis of CSMD1 mRNA expression by in situ hybridization and immunolabeling of neurons indicates that the primary sites of synthesis are the developing CNS and epithelial tissues. Of particular significance is the enrichment of CSMD1 in the nerve growth cone, the amoeboid-leading edge of the growing neuron. These results suggest that CSMD1 may be an important regulator of complement activation and inflammation in the developing CNS, and that it may also play a role in the context of growth cone function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547280     DOI: 10.4049/jimmunol.176.7.4419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Complement genetics, deficiencies, and disease associations.

Authors:  Karine R Mayilyan
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 3.  Genome-wide association studies of schizophrenia: does bigger lead to better results?

Authors:  Sarah E Bergen; Tracey L Petryshen
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

4.  Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

Authors:  Rui Zhang; Chun Song
Journal:  Tumour Biol       Date:  2014-01-10

Review 5.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts.

Authors:  Ken H Loh; Philipp S Stawski; Austin S Draycott; Namrata D Udeshi; Emily K Lehrman; Daniel K Wilton; Tanya Svinkina; Thomas J Deerinck; Mark H Ellisman; Beth Stevens; Steven A Carr; Alice Y Ting
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

7.  Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach.

Authors:  Matteo Fumagalli; Uberto Pozzoli; Rachele Cagliani; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  PLoS Genet       Date:  2010-02-19       Impact factor: 5.917

8.  The landscape of human genes involved in the immune response to parasitic worms.

Authors:  Matteo Fumagalli; Uberto Pozzoli; Rachele Cagliani; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  BMC Evol Biol       Date:  2010-08-31       Impact factor: 3.260

9.  Identification of a rare de novo three-way complex t(5;20;8)(q31;p11.2;p21) with microdeletions on 5q31.2, 5q31.3, and 8p23.2 in a patient with hearing loss and global developmental delay: case report.

Authors:  Roland Haj; Kelly Jackson; Beth A Torchia; Lisa G Shaffer; Bassem A Bejjani; Gordon C Gowans; Michael W Ruff
Journal:  Mol Cytogenet       Date:  2009-01-07       Impact factor: 2.009

10.  A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease.

Authors:  David Burgner; Sonia Davila; Willemijn B Breunis; Sarah B Ng; Yi Li; Carine Bonnard; Ling Ling; Victoria J Wright; Anbupalam Thalamuthu; Miranda Odam; Chisato Shimizu; Jane C Burns; Michael Levin; Taco W Kuijpers; Martin L Hibberd
Journal:  PLoS Genet       Date:  2009-01-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.